As I highlighted in my previous blog, A Look at Human Longevity & Life Expectancy, our global population is experiencing a significant and rapid increase in its aging demographic. For instance, Germany is projected...read more
Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and...read more
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No...read more
PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit...read more
New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first time SAN DIEGO, May 29, 2025 /PRNewswire/ — Illumina Inc...read more
Bean Fixing the Planet: Sustainable Nitrogen for Better Planetary Health Nitrogen plays a vital role as a fundamental component in the creation of life’s essentials, such as nucleotides and proteins. The introduction of...read more
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology, with an initial focus on critically ill newborns and their parents. Whole genome...read more
For decades, there has been a growing understanding of antibiotic overuse and the increasing prevalence of infections resistant to first-line treatment. The magnitude of this issue, now broadly recognized as...read more
Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court...read more
Partnership will build a global AI-powered healthcare platform to deliver more effective, scalable, and affordable care Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a...read more
I wanted to provide some guidance and best practices around marketing automation attribution models, which I hope will be helpful and gives you some insight. I’m sure we all embrace data-driven marketing. That said, in...read more
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use...read more
An artificial intelligence (AI) model is being trained on a set of NHS data for 57 million people in England, from which personal information has been stripped away, in a world-first pilot project run by researchers at...read more
Driven by a personal interest in human longevity, I’ve explored the extensive discourse surrounding this topic. It’s a subject that captivates both the general public and the scientific community, whether...read more
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information...read more
The Bio-IT World Conference & Expo, taking place in Boston, April 2-4, has grown into a highly regarded, must-attend conference for life scientists, clinical care, and IT professionals. The program focuses on new...read more
Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level...read more
A recent paper that has been generating energetic discussions and debate about Artificial Intelligence (AI), and its implications for biological discovery was published on the bioRxiv site on Feb 21 of this year (Brixi...read more
For the first time, large-scale DNA sequence data on three UK long-term birth cohorts has been released, creating a unique resource to explore the relationship between genetic and environmental factors in child health...read more
While a lot more than “sequencing” has been the news from AGBT 2025, with this post I wanted to focus predominantly on some highlights from the “sequencing” category. Clearly, Roche’s SBX Nanopore Sequencing stole the...read more
A blurry band on a gel during a chemistry experiment didn’t show conclusive results, but there was still enough there to warrant further exploration. Years before, biochemist Mark Kokoris and his colleagues had begun a...read more
Marking its return to the next-generation sequencing (NGS) space. SBX introduces a new biochemical approach designed to address the limitations of current sequencing technologies, particularly in speed, scalability, and...read more
2024 was a true testimony to the fact that we are positioned at the intersection of significant AI opportunities and this in parallel to trends in declining costs of next-generation sequencing (NGS): healthcare...read more
Reactive oxygen species (ROS) are a feature of all living eukaryotic cells, normal or cancerous. Maintaining redox homeostasis is a complex and delicate balance involving numerous biochemical production and defense...read more
Comparisons between anthropological and genomic ancestry assignments for UHRs reveals significant discordance, shedding light on the challenges in determining population affinity, particularly for admixed populations...read more
Protecting the genetic privacy of folks that help solve crimes or identify human remains, is of the utmost importance to Othram, the world’s first private DNA laboratory built specifically to apply the power of modern...read more
As the artificial intelligence (AI) revolution picks up momentum, it is important for us not to lose focus on innovation within the healthcare data ecosystem. We stand at the brink of a transformative era where the deep...read more
Study details the unprecedented scale, diversity, and power of the All of Us Research Program Researchers have discovered more than 275 million previously unreported genetic variants, identified from data shared by...read more
Contact me to get the spreadsheet with full data I used for my analysis. As a CEO of an early-stage biotech company (Neurolentech) operating in the spaceof neurodevelopmental diseases (NDDs), I spend a significant part...read more
Innovative approach integrates genetic data to identify drug targets with high potential for clinical trial success Researchers optimized drug target prioritization to increase odds of clinical trial success by...read more